Diversified Consumer Services
Company Overview of Massachusetts Institute of Technology
Massachusetts Institute of Technology is an academic research and educational institution. The university has five schools that offer degree courses in architecture and planning, engineering, humanities, arts, and social sciences, management, and science. These include twenty-seven degree-granting departments, programs, and divisions. Massachusetts Institute of Technology was founded in 1861 and is based in Cambridge, Massachusetts.
77 Massachusetts Avenue
Cambridge, MA 02139-4307
Founded in 1861
Key Executives for Massachusetts Institute of Technology
First Vice President and General Counsel
Professor of David H. Koch Institute
Compensation as of Fiscal Year 2014.
Massachusetts Institute of Technology Key Developments
MIT Names Lorraine A. Goffe-Rush as Vice President for Human Resources
Dec 17 14
Lorraine A. Goffe-Rush, who is now vice chancellor for human resources at Washington University in St. Louis, will join MIT in February as its next vice president for human resources. Goffe-Rush has worked in human resources at Washington University since 2000.
Massachusetts Institute of Technology Names Tomasz S. Mrowka as Head of Department of Mathematics
Dec 10 14
Massachusetts Institute of Technology announced Tomasz S. Mrowka, the Singer Professor of Mathematics, has been named head of the Department of Mathematics, effective immediately. Mrowka has served as the interim department head since June 2014. Mrowka takes over the role from Michael Sipser, the Barton L. Weller Professor of Mathematics. Sipser was named Dean of the School of Science after serving since last December as interim dean and since 2004 as head of the Department of Mathematics.
The Broad Institute, Harvard University, The Massachusetts Institute of Technology and Editas Medicine Enter into Worldwide License Agreement
Dec 1 14
The Broad Institute, Harvard University, The Massachusetts Institute of Technology and Editas Medicine have entered into a worldwide license agreement to grant Editas access to intellectual property related to certain genome editing technology for the development of human therapeutic applications. The agreement relates to technology that engineers the CRISPR-Cas9 system-a naturally-occurring part of the bacterial immune system. Researchers at Harvard Medical School, the Wyss Institute for Biologically Inspired Engineering at Harvard University, Broad Institute, MIT, the McGovern Institute for Brain Research at MIT, and Harvard University Faculty of Arts and Sciences (FAS), have optimized the CRISPR-Cas9 system to allow for insertion, replacement, and regulation of targeted genes in higher organisms, with the potential to one day be used in humans. This technology has wide-ranging therapeutic potential and could lay the groundwork for treating diseases where a gene's expression needs to be altered (such as turning down CCR5 in HIV), or where a mutation needs to be repaired (such as sickle cell diseases or hemophilia). In addition to their therapeutic implications, CRISPR-Cas9 systems enable scientists to modify genes and better understand the biology of living cells and organisms.
Similar Private Companies By Industry
Recent Private Companies Transactions